๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Rectal apomorphine in Parkinson's disease

โœ Scribed by Hughes, AndrewJ.; Bishop, Sue; Lees, AndrewJ.; Stern, GeraldM.; Webster, Roy; Bovingdon, Michael

Book ID
122705890
Publisher
The Lancet
Year
1991
Tongue
English
Weight
176 KB
Volume
337
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetics and clinical efficacy o
Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: A study of five different suppositories
โœ Dr. T. van Laar; E. N. H. Jansen; C. Neef; M. Danhof; R. A. C. Roos ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 568 KB

## Abstract The pharmacokinetics and clinical effects of apomorphine after rectal administration were determined in five patients with idiopathic Parkinson's disease (PD). Three different pharmaceutical formulations were tested: a rectal solution of apomorphine (10 or 15 mg), a gelatin suppository

Parkinson's disease/Parkinson syndromesโ€”
Parkinson's disease/Parkinson syndromesโ€”apomorphine
๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 381 KB

We report clinical data on six Parkinsonian patients on long term L-dopa therapy who complained of short, but clear deterioration of parkinsonian symptoms imediatly after L-dopa intake. After an oral challenge with 275mg L-dopdcarbidopa (and apomorphine 3mg SC in two cases) patients were assessed e

SUBCUTANEOUS APOMORPHINE IN PARKINSON'S
SUBCUTANEOUS APOMORPHINE IN PARKINSON'S DISEASE
โœ Poewe, Werner; Kleedorfer, Birgit; Gerstenbrand, Franz; ร–ertel, Wolfgang ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› The Lancet ๐ŸŒ English โš– 170 KB